Ebby Varghese, MD
Pain Medicine · Columbia, MONPI 1639200942
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,343 of the $8,327 with a category attached, or 76.2%. Abbott accounts for 78.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $2,319 and has fallen 64.9% since, to $814 in 2025.
Across 208 payments — averaging $40.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$7K
- Pacira Pharmaceuticals Incorporated$636
- Medtronic$626
- MML US, Inc.$180
- Pfizer$150
- Globus Medical$112
- plus $121 from 3 others
What the payments were for
- Travel & lodging$1,98424%
- Food & beverage$6,34376%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 171 | $6,501 |
| Pacira Pharmaceuticals Incorporated | 5 | $636 |
| Medtronic(2 entities) | 15 | $626 |
| MML US, Inc. | 2 | $180 |
| Pfizer | 7 | $150 |
| Globus Medical | 1 | $112 |
| Nevro Corp. | 4 | $63 |
| AbbVie | 2 | $45 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,622
- Proclaim Family of SCS IPGs$697
- IOVERA SYSTEM$604
- Proclaim IPG$271
- ETERNA$251
- RESTORE$207
- ReActiv8$168
- INTELLIS ADAPTIVESTIM$164
- Senza$112
How this compares
$8,327 in reported general payments places this provider in the 80th percentile of 124 pain medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 35 | $34,099 |
| OxycontinOxycodone Hcl | 11 | $1,564 |
| Pregabalin | 26 | $1,495 |
| Morphine Sulfate ErMorphine Sulfate | 54 | $1,141 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 55 | $1,122 |
| Oxycodone Hcl | 80 | $1,083 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 49 | $1,008 |
| Diclofenac Sodium | 19 | $941 |
| Tramadol Hcl | 59 | $602 |
| Gabapentin | 30 | $316 |
| Baclofen | 42 | $264 |
| Hydromorphone Hcl | 14 | $216 |
| Amitriptyline Hcl | 13 | $142 |
| Topiramate | 21 | $130 |
| Duloxetine Hcl | 15 | $123 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Columbia
- Abram ElsenraatColumbia$14K
- Donald MeyerColumbia$8K
- Shady Adib KelehColumbia$7K
- Richard WolkowitzColumbia$3K
- Christopher ReisCape Girardeau$113K
- Anne ChristopherChesterfield$104K
- Tyler ConcannonKansas City$64K
- Vinicius Tieppo FrancioSaint Louis$35K
- Luvell GlantonHannibal$33K
- Jooyoung MaengSaint Louis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.